PubRank

Martin Knapp

Author PubWeight™ 197.04‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Resources for mental health: scarcity, inequity, and inefficiency. Lancet 2007 11.54
2 Sertraline or mirtazapine for depression in dementia (HTA-SADD): a randomised, multicentre, double-blind, placebo-controlled trial. Lancet 2011 6.09
3 Effect of telehealth on use of secondary care and mortality: findings from the Whole System Demonstrator cluster randomised trial. BMJ 2012 5.87
4 Donepezil and memantine for moderate-to-severe Alzheimer's disease. N Engl J Med 2012 5.64
5 Cost of disorders of the brain in Europe 2010. Eur Neuropsychopharmacol 2011 4.63
6 Donepezil for the treatment of agitation in Alzheimer's disease. N Engl J Med 2007 4.11
7 The effectiveness of supported employment for people with severe mental illness: a randomised controlled trial. Lancet 2007 4.01
8 Cost effectiveness of telehealth for patients with long term conditions (Whole Systems Demonstrator telehealth questionnaire study): nested economic evaluation in a pragmatic, cluster randomised controlled trial. BMJ 2013 3.69
9 Poverty and mental disorders: breaking the cycle in low-income and middle-income countries. Lancet 2011 3.64
10 Training carers of stroke patients: randomised controlled trial. BMJ 2004 2.95
11 Antidepressant medications and other treatments of depressive disorders: a CINP Task Force report based on a review of evidence. Int J Neuropsychopharmacol 2007 2.60
12 A randomized, controlled trial with 6-month follow-up of repetitive transcranial magnetic stimulation and electroconvulsive therapy for severe depression. Am J Psychiatry 2007 2.48
13 Mental health policy development and implementation in four African countries. J Health Psychol 2007 2.45
14 Exploring barriers to participation and adoption of telehealth and telecare within the Whole System Demonstrator trial: a qualitative study. BMC Health Serv Res 2012 2.29
15 Cost-effectiveness of computerised cognitive-behavioural therapy for anxiety and depression in primary care: randomised controlled trial. Br J Psychiatry 2004 2.06
16 Cognitive remediation therapy in schizophrenia: randomised controlled trial. Br J Psychiatry 2007 2.06
17 Effect of telecare on use of health and social care services: findings from the Whole Systems Demonstrator cluster randomised trial. Age Ageing 2013 1.97
18 Depression status, medical comorbidity and resource costs. Evidence from an international study of major depression in primary care (LIDO). Br J Psychiatry 2003 1.91
19 Evidence-based guidelines for the pharmacological treatment of anxiety disorders: recommendations from the British Association for Psychopharmacology. J Psychopharmacol 2005 1.88
20 Alternative strategies for stroke care: cost-effectiveness and cost-utility analyses from a prospective randomized controlled trial. Stroke 2003 1.74
21 A comprehensive evaluation of the impact of telemonitoring in patients with long-term conditions and social care needs: protocol for the whole systems demonstrator cluster randomised trial. BMC Health Serv Res 2011 1.72
22 Economic impact of services for first-episode psychosis: a decision model approach. Early Interv Psychiatry 2009 1.71
23 Clinical effectiveness of a manual based coping strategy programme (START, STrAtegies for RelaTives) in promoting the mental health of carers of family members with dementia: pragmatic randomised controlled trial. BMJ 2013 1.70
24 Effect of telehealth on quality of life and psychological outcomes over 12 months (Whole Systems Demonstrator telehealth questionnaire study): nested study of patient reported outcomes in a pragmatic, cluster randomised controlled trial. BMJ 2013 1.67
25 The economic impact of chronic pain in adolescence: methodological considerations and a preliminary costs-of-illness study. Pain 2005 1.64
26 A comparison of two methods of collecting economic data in primary care. Fam Pract 2005 1.59
27 Cost of schizophrenia in England. J Ment Health Policy Econ 2007 1.58
28 Barriers in the mind: promoting an economic case for mental health in low- and middle-income countries. World Psychiatry 2008 1.54
29 Improving the measurement of QALYs in dementia: developing patient- and carer-reported health state classification systems using Rasch analysis. Value Health 2011 1.52
30 Modelling the impact of clozapine on suicide in patients with treatment-resistant schizophrenia in the UK. Br J Psychiatry 2003 1.50
31 Relapse in schizophrenia: costs, clinical outcomes and quality of life. Br J Psychiatry 2004 1.44
32 Training care givers of stroke patients: economic evaluation. BMJ 2004 1.44
33 Predictors of employment for people with severe mental illness: results of an international six-centre randomised controlled trial. Br J Psychiatry 2008 1.43
34 The costs of early intervention in psychosis: restoring the balance. Aust N Z J Psychiatry 2012 1.40
35 Income-related inequalities in the prevalence of depression and suicidal behaviour: a 10-year trend following economic crisis. World Psychiatry 2011 1.39
36 Individual budget projects come under the microscope. Ment Health Today 2009 1.38
37 Clinical practice with anti-dementia drugs: a consensus statement from British Association for Psychopharmacology. J Psychopharmacol 2006 1.29
38 Multiple sclerosis in the UK: service use, costs, quality of life and disability. Pharmacoeconomics 2008 1.28
39 Determining the minimum clinically important differences for outcomes in the DOMINO trial. Int J Geriatr Psychiatry 2010 1.26
40 Cognitive impairment in older people: future demand for long-term care services and the associated costs. Int J Geriatr Psychiatry 2007 1.26
41 People with schizophrenia in five countries: conceptual similarities and intercultural differences in family caregiving. Schizophr Bull 2003 1.25
42 The personal impact of schizophrenia in Europe. Schizophr Res 2004 1.24
43 Economic cost of severe antisocial behaviour in children--and who pays it. Br J Psychiatry 2006 1.24
44 Housing services for people with mental disorders in England: patient characteristics, care provision and costs. Soc Psychiatry Psychiatr Epidemiol 2009 1.18
45 Children in foster care: mental health, service use and costs. Eur Child Adolesc Psychiatry 2006 1.16
46 Evidence of cost-effective treatments for depression: a systematic review. J Affect Disord 2005 1.16
47 Main determinants of Global Assessment of Functioning score in schizophrenia: a European multicenter study. Compr Psychiatry 2005 1.16
48 An organisational analysis of the implementation of telecare and telehealth: the whole systems demonstrator. BMC Health Serv Res 2012 1.15
49 Measuring the parental, service and cost impacts of children with autistic spectrum disorder: a pilot study. J Autism Dev Disord 2003 1.14
50 The mental health consequences of the recession: economic hardship and employment of people with mental health problems in 27 European countries. PLoS One 2013 1.13
51 The economic consequences of social phobia. J Affect Disord 2002 1.11
52 A comparison of SF-6D and EQ-5D utility scores in a study of patients with schizophrenia. J Ment Health Policy Econ 2009 1.10
53 Annotation: Economic evaluations of child and adolescent mental health interventions: a systematic review. J Child Psychol Psychiatry 2005 1.07
54 Financial incentives to improve adherence to anti-psychotic maintenance medication in non-adherent patients - a cluster randomised controlled trial (FIAT). BMC Psychiatry 2009 1.06
55 The cost of schizophrenia in Japan. Neuropsychiatr Dis Treat 2013 1.05
56 Cost-utility analysis of intravenous immunoglobulin and prednisolone for chronic inflammatory demyelinating polyradiculoneuropathy. Eur J Neurol 2003 1.04
57 Income-related inequalities in common mental disorders among ethnic minorities in England. Soc Psychiatry Psychiatr Epidemiol 2011 1.01
58 Comparison of alternative methods of collection of service use data for the economic evaluation of health care interventions. Health Econ 2007 1.01
59 Peer support for family carers of people with dementia, alone or in combination with group reminiscence in a factorial design: study protocol for a randomised controlled trial. Trials 2011 1.00
60 Income-related inequality in mental health in Britain: the concentration index approach. Psychol Med 2007 0.99
61 The Barcelona declaration on bridging knowledge in long-term care and support. Barcelona (Spain), March 7, 2009. Int J Integr Care 2009 0.98
62 Hidden costs of mental illness. Br J Psychiatry 2003 0.98
63 Adaptive pacing, cognitive behaviour therapy, graded exercise, and specialist medical care for chronic fatigue syndrome: a cost-effectiveness analysis. PLoS One 2012 0.98
64 The effect of telecare on the quality of life and psychological well-being of elderly recipients of social care over a 12-month period: the Whole Systems Demonstrator cluster randomised trial. Age Ageing 2013 0.98
65 Maintenance Cognitive Stimulation Therapy (CST) for dementia: a single-blind, multi-centre, randomized controlled trial of Maintenance CST vs. CST for dementia. Trials 2010 0.96
66 Individual Cognitive Stimulation Therapy for dementia (iCST): study protocol for a randomized controlled trial. Trials 2012 0.96
67 Costs of depression in Catalonia (Spain). J Affect Disord 2011 0.96
68 Resource-use measurement based on patient recall: issues and challenges for economic evaluation. Appl Health Econ Health Policy 2013 0.95
69 Differential effects of manual assisted cognitive behavior therapy in the treatment of recurrent deliberate self-harm and personality disturbance: the POPMACT study. J Pers Disord 2004 0.95
70 Estimating preference-based single index measures for dementia using DEMQOL and DEMQOL-Proxy. Value Health 2012 0.95
71 Cost-impact of young adults with high-functioning autistic spectrum disorder. Res Dev Disabil 2006 0.95
72 Schizophrenia patients with cognitive deficits: factors associated with costs. Schizophr Bull 2006 0.92
73 Design of an internet-based health economic evaluation of a preventive group-intervention for children of parents with mental illness or substance use disorders. BMC Public Health 2010 0.91
74 Goal-oriented cognitive rehabilitation in early-stage dementia: study protocol for a multi-centre single-blind randomised controlled trial (GREAT). Trials 2013 0.91
75 Interleukin 8 (IL-8) - a universal biomarker? Int Arch Med 2010 0.90
76 Economic aspects of the association between diabetes and depression: a systematic review. J Affect Disord 2012 0.90
77 Satisfaction with mental health services among people with schizophrenia in five European sites: results from the EPSILON Study. Schizophr Bull 2003 0.90
78 Differences in photosynthetic activity, chlorophyll and carotenoid levels, and in chlorophyll fluorescence parameters in green sun and shade leaves of Ginkgo and Fagus. J Plant Physiol 2006 0.89
79 Economic impact of personality disorders in UK primary care attenders. Br J Psychiatry 2002 0.89
80 Service use and cost of mental disorder in older adults with intellectual disability. Br J Psychiatry 2010 0.89
81 The Maudsley long-term follow-up of child and adolescent depression. Predicting costs in adulthood. Eur Child Adolesc Psychiatry 2005 0.89
82 Cognitive remediation therapy in schizophrenia: cost-effectiveness analysis. Schizophr Res 2010 0.89
83 The economic impact of early intervention in psychosis services for children and adolescents. Early Interv Psychiatry 2013 0.89
84 A randomised controlled trial of intravenous immunoglobulin in IgM paraprotein associated demyelinating neuropathy. J Neurol 2002 0.89
85 Factor solution of the BPRS-expanded version in schizophrenic outpatients living in five European countries. Schizophr Res 2005 0.88
86 Financing mental health services in low- and middle-income countries. Health Policy Plan 2006 0.88
87 Criminal outcomes and costs of treatment services for injecting and non-injecting heroin users: evidence from a national prospective cohort survey. J Health Serv Res Policy 2003 0.88
88 Economic impact of childhood psychiatric disorder on public sector services in Britain: estimates from national survey data. J Child Psychol Psychiatry 2013 0.88
89 Economic evaluation of early intervention services. Br J Psychiatry Suppl 2007 0.87
90 Does telecare prolong community living in dementia? A study protocol for a pragmatic, randomised controlled trial. Trials 2013 0.86
91 A cluster randomized controlled trial of a structured training programme for caregivers of inpatients after stroke (TRACS). Int J Stroke 2011 0.86
92 Schizophrenia--time to commit to policy change. Schizophr Bull 2014 0.86
93 DOMINO-AD protocol: donepezil and memantine in moderate to severe Alzheimer's disease - a multicentre RCT. Trials 2009 0.86
94 Good friends are hard to find? The social networks of people with mental illness 12 years after deinstitutionalisation. J Ment Health 2011 0.85
95 UK cost-consequence analysis of aripiprazole in schizophrenia: diabetes and coronary heart disease risk projections (STAR study). Eur Arch Psychiatry Clin Neurosci 2009 0.85
96 Cost-utility of cognitive behavioral therapy versus U.S. Food and Drug Administration recommended drugs and usual care in the treatment of patients with fibromyalgia: an economic evaluation alongside a 6-month randomized controlled trial. Arthritis Res Ther 2014 0.84
97 Cost-effectiveness analyses for mirtazapine and sertraline in dementia: randomised controlled trial. Br J Psychiatry 2012 0.84
98 "The trouble with QALYs...". Epidemiol Psichiatr Soc 2008 0.84
99 Geographical inequalities in suicide rates and area deprivation in South Korea. J Ment Health Policy Econ 2013 0.84
100 Caring for people with depression or with schizophrenia: are the consequences different? Psychiatry Res 2009 0.83
101 The EPSILON Study - a study of care for people with schizophrenia in five European centres. World Psychiatry 2002 0.83
102 Modelling the treated course of schizophrenia: development of a discrete event simulation model. Pharmacoeconomics 2005 0.83
103 Mental health expenditure in England: a spatial panel approach. J Health Econ 2007 0.82
104 Does integrated governance lead to integrated patient care? Findings from the innovation forum. Health Soc Care Community 2013 0.82
105 Impact of macro-level socio-economic factors on rising suicide rates in South Korea: panel-data analysis in East Asia. J Ment Health Policy Econ 2014 0.82
106 Feasibility study of an optimised person-centred intervention to improve mental health and reduce antipsychotics amongst people with dementia in care homes: study protocol for a randomised controlled trial. Trials 2013 0.82
107 Posttraumatic stress disorder (PTSD) in the Armed Forces: health economic considerations. J Trauma Stress 2003 0.82
108 Treatment paths and costs for young adults with acquired brain injury in the United Kingdom. Brain Inj 2009 0.81
109 Exploring resource use and associated costs in end-of-life care for older people with dementia in residential care homes. Int J Geriatr Psychiatry 2013 0.81
110 Cost-effectiveness of cognitive behaviour therapy in addition to mebeverine for irritable bowel syndrome. Eur J Gastroenterol Hepatol 2008 0.81
111 Routine outcome monitoring in clinical practice: service and non-service costs of psychiatric patients attending a Community Mental Health Centre in Italy. Eur Psychiatry 2004 0.81
112 Future costs of dementia-related long-term care: exploring future scenarios. Int Psychogeriatr 2010 0.81
113 Reported goal setting and benefits of person centred planning for people with intellectual disabilities. J Intellect Disabil 2008 0.81
114 The economic costs of dementia in Korea, 2002. Int J Geriatr Psychiatry 2006 0.81
115 Cost-utility of a psychoeducational intervention in fibromyalgia patients compared with usual care: an economic evaluation alongside a 12-month randomized controlled trial. Clin J Pain 2013 0.81
116 Black-skies planning? Prioritising mental health services in times of austerity. Br J Psychiatry 2010 0.81
117 The use of fluorescence correlation spectroscopy (FCS) as an alternative biomarker detection technique: a preliminary study. J Cell Mol Med 2011 0.81
118 Patient education methods to support quality of life and functional ability among patients with schizophrenia: a randomised clinical trial. Qual Life Res 2011 0.81
119 Exploring the spatial pattern of mental health expenditure. J Ment Health Policy Econ 2005 0.81
120 Exploring the cost-effectiveness of a one-off screen for dementia (for people aged 75 years in England and Wales). Int J Geriatr Psychiatry 2014 0.80
121 Emerging applications of fluorescence spectroscopy in medical microbiology field. J Transl Med 2009 0.80
122 The economic costs of progressive supranuclear palsy and multiple system atrophy in France, Germany and the United Kingdom. PLoS One 2011 0.79
123 Treatment and prevention of depression after surgery for hip fracture in older people: cost-effectiveness analysis. J Affect Disord 2010 0.79
124 The local burden of emotional disorders. An analysis based on a large health survey in Catalonia (Spain). Gac Sanit 2011 0.79
125 The effectiveness of technology-based patient education on self-reported deprivation of liberty among people with severe mental illness: a randomized controlled trial. Nord J Psychiatry 2009 0.79
126 Longitudinal analysis of the impact and cost of person-centered planning for people with intellectual disabilities in England. Am J Ment Retard 2006 0.78
127 The relationship between changes in quality of life outcomes and progression of Alzheimer's disease: results from the dependence in AD in England 2 longitudinal study. Int J Geriatr Psychiatry 2014 0.78
128 Cost-effectiveness of combination therapy versus antidepressant therapy for management of depression in Japan. Aust N Z J Psychiatry 2009 0.78
129 Improving Well-being and Health for People with Dementia (WHELD): study protocol for a randomised controlled trial. Trials 2014 0.78
130 Health and social care costs for young adults with epilepsy in the UK. Health Soc Care Community 2010 0.78
131 Slicing the health service cake: the Islington study. Age Ageing 2002 0.78
132 Cost analysis of treating schizophrenia with amisulpride: naturalistic mirror image study. Prog Neuropsychopharmacol Biol Psychiatry 2005 0.78
133 Treatment costs for depression with pain and cardiovascular comorbidities. J Psychiatr Res 2012 0.78
134 Protocol of a cluster randomized trial evaluation of a patient and carer-centered system of longer-term stroke care (LoTS care). Int J Stroke 2013 0.78
135 Outcome measures used in forensic mental health research: a structured review. Crim Behav Ment Health 2009 0.77
136 The economics of schizophrenia care in Europe: the EPSILON study. Epidemiol Psichiatr Soc 2002 0.77
137 Cost-effectiveness of adherence therapy versus health education for people with schizophrenia: randomised controlled trial in four European countries. Cost Eff Resour Alloc 2013 0.77
138 Effects of the implementation of the web-based patient support system on staff's attitudes towards computers and IT use: a randomised controlled trial. Scand J Caring Sci 2010 0.77
139 Equity in mental health. Epidemiol Psichiatr Soc 2007 0.77
140 Methodological approach for assessing the cost-effectiveness of treatments using longitudinal observational data: the SOHO study. Int J Technol Assess Health Care 2006 0.77
141 Outcomes and costs of community living: semi-independent living and fully staffed group homes. Am J Ment Retard 2008 0.77
142 The costs and effectiveness of two psychosocial treatment programmes for personality disorder: a controlled study. Eur Psychiatry 2005 0.76
143 Cost-effectiveness comparisons between antidepressant treatments in depression: evidence from database analyses and prospective studies. J Affect Disord 2011 0.76
144 Quality and costs of community-based residential supports for people with mental retardation and challenging behavior. Am J Ment Retard 2004 0.76
145 Service variation in baseline variables and prediction of risk in a randomised controlled trial of psychological treatment in repeated parasuicide: the POPMACT Study. Int J Soc Psychiatry 2003 0.76
146 A hidden face of community mental health care in Africa: specialist care from private providers in Kenya. World Psychiatry 2014 0.75
147 The cost-effectiveness of mirtazapine versus paroxetine in treating people with depression in primary care. Int Clin Psychopharmacol 2004 0.75
148 Timing of drug treatment is crucial. BMJ 2004 0.75
149 The economic impact of initiatives to reduce stigma: demonstration of a modelling approach. Epidemiol Psichiatr Soc 2010 0.75
150 Our panel of experts highlight the most important research articles across the spectrum of topics relevant to the field of neurodegenerative disease management. Neurodegener Dis Manag 2015 0.75
151 Dementia: a new global epidemic? Maturitas 2010 0.75
152 The conduct of successful multi-site EU collaborative research: the EPSILON Study. Epidemiol Psichiatr Soc 2002 0.75
153 The iceberg tip and the rest. Mental health care for people with schizophrenia in five European centres. Epidemiol Psichiatr Soc 2002 0.75
154 Meeting the challenge of funding and allocating resources to mental health across Europe: developing the Mental Health Economics European Network. Epidemiol Psichiatr Soc 2006 0.75
155 Sur model with spatial effects: an application to mental health expenditure. Health Econ 2007 0.75
156 Protecting nanoscaled non-oxidic particles from oxygen uptake by coating with nitrogen-containing surfactants. Langmuir 2004 0.75
157 The cost of relapse for patients with a manic/mixed episode of bipolar disorder in the EMBLEM study. Pharmacoeconomics 2010 0.75
158 The development of a Local Index of Need (LIN) and its use to explain variations in social services expenditure on mental health care in England. Health Soc Care Community 2006 0.75
159 Service use and costs of supporting the most socially disabled patients in a hospital reprovision programme. A two-hospital comparison. Soc Psychiatry Psychiatr Epidemiol 2006 0.75
160 Costs and cognitive disability: modelling the underlying associations. Br J Psychiatry 2002 0.75
161 Public funding of pharmaceuticals in The Netherlands: investigating the effect of evidence, process and context on CVZ decision-making. Eur J Health Econ 2013 0.75